In summary, this study demonstrates that miR-199a, when delivered by hMSCs via the exosomes, is able to negatively regulate the expression of AGAP2, thereby inhibiting the proliferation and enhancing apoptosis of glioma cells (Figure 11). The gene discussed is AGAP2; the disease is glioma.